{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:22:22Z","timestamp":1760955742134,"version":"build-2065373602"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.rmed.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T04:45:22Z","timestamp":1502253922000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction"],"prefix":"10.1016","volume":"131","author":[{"given":"Sandeep","family":"Sahay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-4676","authenticated-orcid":false,"given":"Ghaleb","family":"Khirfan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano R.","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2017.08.006_bib1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.rmed.2017.08.006_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtcvs.2004.04.044","article-title":"Left ventricular assist devices as destination therapy: a new look at survival","volume":"129","author":"Park","year":"2005","journal-title":"J.\u00a0Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2006.09.124","article-title":"Improving outcomes with long-term \u2018destination\u2019 therapy using left ventricular assist devices","volume":"135","author":"Long","year":"2008","journal-title":"J.\u00a0Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib4","doi-asserted-by":"crossref","unstructured":"A.P. Kalogeropoulos, J.D. Vega, A.L. Smith, & V.V. Georgiopoulou, Pulmonary hypertension and right ventricular function in advanced heart failure, Congest. Heart Fail. 17, 189\u2013198.","DOI":"10.1111\/j.1751-7133.2011.00234.x"},{"key":"10.1016\/j.rmed.2017.08.006_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.athoracsur.2006.08.051","article-title":"Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices","volume":"83","author":"Klodell","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.healun.2010.02.004","article-title":"Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension","volume":"29","author":"Perez-Villa","year":"2010","journal-title":"J.\u00a0Heart Lung Transpl."},{"key":"10.1016\/j.rmed.2017.08.006_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11936-013-0267-0","article-title":"Management of right ventricular failure in pulmonary hypertension (and after LVAD implantation)","volume":"15","author":"Palmer","year":"2013","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.rmed.2017.08.006_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.healun.2010.12.006","article-title":"Fixed pulmonary hypertension and mechanical support: an unclear opportunity","volume":"30","author":"Uriel","year":"2011","journal-title":"J.\u00a0Heart Lung Transpl."},{"key":"10.1016\/j.rmed.2017.08.006_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-5223(97)70053-9","article-title":"Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality","volume":"114","author":"Chen","year":"1997","journal-title":"J.\u00a0Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1053-2498(00)00138-8","article-title":"The registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000","volume":"19","author":"Hosenpud","year":"2000","journal-title":"J.\u00a0Heart Lung Transpl."},{"key":"10.1016\/j.rmed.2017.08.006_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healun.2003.09.045","article-title":"Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation","volume":"24","author":"Butler","year":"2005","journal-title":"J.\u00a0Heart Lung Transpl."},{"key":"10.1016\/j.rmed.2017.08.006_bib12","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2017.08.006_bib13","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","article-title":"Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management","volume":"102","author":"Moraes","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2017.08.006_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology ( ESC ) and the European respiratory Society ( ERS )","volume":"37","author":"Galie","year":"2016","journal-title":"Eur. Hear. J."},{"year":"1986","series-title":"Profiles in Valvular Heart Disease","author":"Grossman","key":"10.1016\/j.rmed.2017.08.006_bib15"},{"key":"10.1016\/j.rmed.2017.08.006_bib16","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/01.CIR.0000034444.31846.F4","article-title":"Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan","volume":"106","author":"Ooi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2017.08.006_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0002-9149(98)00400-7","article-title":"The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure","volume":"82","author":"Cooper","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.rmed.2017.08.006_bib18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrcardio.2010.144","article-title":"Pulmonary hypertension with left-sided heart disease","volume":"7","author":"Guazzi","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.rmed.2017.08.006_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejheart.2004.10.021","article-title":"Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure","volume":"7","author":"Delgado","year":"2005","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.rmed.2017.08.006_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.1700950213","article-title":"Hypertensive pulmonary vascular disease in states of chronic hypoxia","volume":"95","author":"Hasleton","year":"1968","journal-title":"J.\u00a0Pathol. Bacteriol."},{"key":"10.1016\/j.rmed.2017.08.006_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/thx.50.2.210","article-title":"Severe pulmonary vascular change in patients dying with right ventricular failure after heart transplantation","volume":"50","author":"Hasleton","year":"1995","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2017.08.006_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1183\/09031936.00.15111600","article-title":"Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis","volume":"15","author":"Chazova","year":"2000","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2017.08.006_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9149(02)02451-7","article-title":"Usefulness of Endothelin-1 concentration in capillary blood in patients with mitral stenosis as a predictor of regression of pulmonary hypertension after mitral valve replacement or valvuloplasty","volume":"90","author":"Pogorzelska","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.rmed.2017.08.006_bib24","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.107.653576","article-title":"Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle","volume":"117","author":"Haddad","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2017.08.006_bib25","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.transproceed.2007.08.069","article-title":"Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates","volume":"39","author":"Zakliczynski","year":"2007","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.rmed.2017.08.006_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1388-9842(03)00059-X","article-title":"Reversible pulmonary hypertension in heart transplant candidates\u2013pretransplant evaluation and outcome after orthotopic heart transplantation","volume":"5","author":"Klotz","year":"2003","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.rmed.2017.08.006_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.healun.2004.05.013","article-title":"The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report\u20132004","volume":"23","author":"Trulock","year":"2004","journal-title":"J.\u00a0Heart Lung Transpl."},{"key":"10.1016\/j.rmed.2017.08.006_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0735-1097(92)90050-W","article-title":"Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group","volume":"19","author":"Costard-J\u00e4ckle","year":"1992","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2017.08.006_bib29","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0041-1345(99)00436-4","article-title":"Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation: importance in the postoperative morbidity and mortality","volume":"31","author":"Espinoza","year":"1999","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.rmed.2017.08.006_bib30","unstructured":"S. Murali, et\u00a0al., Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension, J. Heart Lung Transplant. 11, 716\u2013723."},{"key":"10.1016\/j.rmed.2017.08.006_bib31","unstructured":"F. Iberer, et\u00a0al., Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation, J. Heart Lung Transplant. 12, 173\u2013178."},{"key":"10.1016\/j.rmed.2017.08.006_bib32","doi-asserted-by":"crossref","unstructured":"H. Haddad, et\u00a0al., Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension, ASAIO J. 51, 456\u2013460.","DOI":"10.1097\/01.mat.0000169125.21268.d7"},{"key":"10.1016\/j.rmed.2017.08.006_bib33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ejcts.2004.01.052","article-title":"Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study","volume":"25","author":"Martin","year":"2004","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib34","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2007.01.019","article-title":"Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices","volume":"83","author":"Etz","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib35","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.healun.2010.06.002","article-title":"Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients","volume":"29","author":"Alba","year":"2010","journal-title":"J.\u00a0Heart Lung Transpl."},{"key":"10.1016\/j.rmed.2017.08.006_bib36","first-page":"767","article-title":"The impact of pulmonary hypertension on outcomes of patients with low left ventricular ejection fraction: a propensity analysis","volume":"21","author":"Yang","year":"2012","journal-title":"J.\u00a0Heart Valve Dis."},{"key":"10.1016\/j.rmed.2017.08.006_bib37","doi-asserted-by":"crossref","first-page":"M733","DOI":"10.1097\/00002480-199609000-00085","article-title":"Pulmonary hypertension is not a risk factor for RVAD use and death after left ventricular assist system support","volume":"42","author":"Smedira","year":"1996","journal-title":"ASAIO J."},{"key":"10.1016\/j.rmed.2017.08.006_bib38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa067758","article-title":"Use of a continuous-flow device in patients awaiting heart transplantation","volume":"357","author":"Miller","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.rmed.2017.08.006_bib39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2009.03.055","article-title":"Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device","volume":"54","author":"Pagani","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2017.08.006_bib40","first-page":"971","article-title":"Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients","volume":"40","author":"Mikus","year":"2011","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcts.2008.12.024","article-title":"Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?","volume":"35","author":"Liden","year":"2009","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/aor.12164","article-title":"Comparison of continuous-flow and pulsatile-flow blood pumps on reducing pulmonary artery pressure in patients with fixed pulmonary hypertension","volume":"37","author":"Ozturk","year":"2013","journal-title":"Artif. Organs"},{"key":"10.1016\/j.rmed.2017.08.006_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.healun.2007.12.001","article-title":"Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading","volume":"27","author":"Garcia","year":"2008","journal-title":"J.\u00a0Hear. Lung Transpl."},{"key":"10.1016\/j.rmed.2017.08.006_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0003-4975(03)01336-5","article-title":"Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support","volume":"77","author":"Klotz","year":"2004","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/CIRCHEARTFAILURE.112.000096","article-title":"Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research","volume":"6","author":"Kalogeropoulos","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.rmed.2017.08.006_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A\u00a0randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am. Heart J."},{"key":"10.1016\/j.rmed.2017.08.006_bib47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2004.05.006","article-title":"Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study","volume":"11","author":"Packer","year":"2005","journal-title":"J.\u00a0Card. Fail."},{"key":"10.1016\/j.rmed.2017.08.006_bib48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.healun.2012.12.004","article-title":"Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients","volume":"32","author":"Kirklin","year":"2013","journal-title":"J.\u00a0Heart Lung Transpl."},{"key":"10.1016\/j.rmed.2017.08.006_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10047-012-0662-4","article-title":"Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device","volume":"16","author":"Imamura","year":"2013","journal-title":"J.\u00a0Artif. Organs"},{"key":"10.1016\/j.rmed.2017.08.006_bib50","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.107.162511","article-title":"Phosphodiesterase type 5: expanding roles in cardiovascular regulation","volume":"101","author":"Kass","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.rmed.2017.08.006_bib51","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1378\/chest.127.5.1647","article-title":"Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide","volume":"127","author":"Lepore","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.08.006_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.106.626226","article-title":"Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure","volume":"115","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2017.08.006_bib53","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","article-title":"Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension","volume":"116","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2017.08.006_bib54","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2174\/092986707781389619","article-title":"The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development","volume":"14","author":"Guazzi","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.rmed.2017.08.006_bib55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cardfail.2007.11.006","article-title":"Effects of 5\u2019-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial","volume":"14","author":"Behling","year":"2008","journal-title":"J.\u00a0Card. Fail."},{"key":"10.1016\/j.rmed.2017.08.006_bib56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","article-title":"PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.rmed.2017.08.006_bib57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCHEARTFAILURE.108.796789","article-title":"PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support","volume":"1","author":"Tedford","year":"2008","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.rmed.2017.08.006_bib58","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/aor.12277","article-title":"Prevention of right heart failure after left ventricular assist device implantation by phosphodiesterase 5 inhibitor","volume":"38","author":"Hamdan","year":"2014","journal-title":"Artif. Organs"},{"key":"10.1016\/j.rmed.2017.08.006_bib59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/aor.12502","article-title":"Clinical outcomes of patients treated with pulmonary vasodilators early and in high dose after left ventricular assist device implantation","volume":"40","author":"Critoph","year":"2016","journal-title":"Artif. Organs"},{"key":"10.1016\/j.rmed.2017.08.006_bib60","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.85.2.504","article-title":"Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure","volume":"85","author":"Cody","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2017.08.006_bib61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0735-1097(95)00520-X","article-title":"Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure","volume":"27","author":"Pacher","year":"1996","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2017.08.006_bib62","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","article-title":"Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure the VERITAS randomized controlled trials","volume":"298","author":"Teerlink","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2017.08.006_bib63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0167-5273(02)00182-1","article-title":"Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?","volume":"85","author":"Kalra","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.rmed.2017.08.006_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1388-9842(99)00022-7","article-title":"Update of REACH-1 and MERIT-HF clinical trials in heart failure. Cardio.net Editorial Team","volume":"1","author":"Mylona","year":"1999","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.rmed.2017.08.006_bib65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/1527029041352135","article-title":"Syndromes of subacute mountain sickness","volume":"5","author":"Anand","year":"2004","journal-title":"High. Alt. Med. Biol."},{"key":"10.1016\/j.rmed.2017.08.006_bib66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchf.2013.12.002","article-title":"Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction","volume":"2","author":"Zile","year":"2014","journal-title":"JACC Hear. Fail."},{"key":"10.1016\/j.rmed.2017.08.006_bib67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000107791","article-title":"Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension\u2013a multi-center randomized study","volume":"109","author":"Kaluski","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.rmed.2017.08.006_bib68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0030-1250726","article-title":"Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation","volume":"60","author":"Hefke","year":"2012","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib69","first-page":"50","volume":"vol 33","author":"Larue","year":"2015"},{"key":"10.1016\/j.rmed.2017.08.006_bib70","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.athoracsur.2012.04.046","article-title":"Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction","volume":"94","author":"Antoniou","year":"2012","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.rmed.2017.08.006_bib71","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.jvca.2013.05.028","article-title":"Effects of early inhaled epoprostenol therapy on pulmonary artery pressure and blood loss during LVAD placement","volume":"28","author":"Groves","year":"2014","journal-title":"J.\u00a0Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.rmed.2017.08.006_bib72","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.113.001458","article-title":"Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study","volume":"128","author":"Bonderman","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2017.08.006_bib73","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.14-0106","article-title":"Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study","volume":"146","author":"Bonderman","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.08.006_bib74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","article-title":"Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure","volume":"34","author":"Erdmann","year":"2013","journal-title":"Eur. Heart J."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461111730269X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461111730269X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:37:51Z","timestamp":1760614671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461111730269X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":74,"alternative-id":["S095461111730269X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2017.08.006","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}